Sinovac vaccine recipients more likely to develop severe COVID-19 than Pfizer: Study
A Singapore study has found that recipients of the Sinovac vaccine are nearly five times more likely to experience severe symptoms from COVID-19 than those who received Pfizer shots. The study involved about 2.7 million adults who received two doses under the national vaccination programme. CNA spoke to Dr Calvin Chiew, Associate Consultant at the National Public Health and Epidemiology Unit at NCID. He is one of the authors of the study.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: / channelnewsasia
Instagram: / channelnewsasia
Twitter: / channelnewsasia
